Showing 621 - 640 results of 63,865 for search '(( 50 ((((ns decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 2 e decrease ))', query time: 1.23s Refine Results
  1. 621
  2. 622
  3. 623

    Loss of <i>Nf1</i> increases sleep fragmentation and decreases sleep depth. by Elizabeth B. Brown (4582978)

    Published 2023
    “…Compared to controls, pan-neuronal knockdown of <i>Nf1</i> significantly reduces sleep during the day (nsyb/+, <i>P</i><0.0001; <i>Nf1</i><sup>RNAi</sup>/+, <i>P</i><0.0001) and night (nsyb/+, <i>P</i><0.0001; <i>Nf1</i><sup>RNAi</sup>/+, <i>P</i><0.0004). <b>E</b>. There is a significant effect of genotype on bout number (two-way ANOVA: F<sub>2,312</sub> = 7.728, <i>P</i><0.0005). …”
  4. 624
  5. 625
  6. 626
  7. 627

    Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses by Jing Wang (6206297)

    Published 2025
    “…Anthropogenic activities, particularly land use change and management practices, alter the global nitrogen (N) cycle. As a central part of the global N cycle, soil N supply from net N mineralization (NNM) and net nitrification (NN) contributes to over 50% of crop N uptake. …”
  8. 628

    IL-6-induction of Nox2 and subsequent decrease of parvalbumin and GAD67 expression in PV-positive interneurons is NFκB-dependent. by Laura L. Dugan (264427)

    Published 2009
    “…(d. e) SN50 also prevented the decrease in expression of parvalbumin and GAD67 induced by IL-6 exposure in PV-interneurons (*F<sub>(2,409)</sub> = 234.7, <i>P</i><0.05; <sup>#</sup>F<sub>(2,409)</sub> = 192.8, <i>P</i><0.05).…”
  9. 629

    Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant by Ittipat Meewan (7455041)

    Published 2019
    “…Hepatitis C virus (HCV) is a human pathogen with high morbidity. The HCV NS3/4A protease is essential for viral replication and is one of the top three drug targets. …”
  10. 630
  11. 631
  12. 632
  13. 633

    Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia by Mary E. Irwin (293687)

    Published 2013
    “…In two human Ph+ALL cell lines, inhibition of ErbB kinase activity with canertinib resulted in a dose-dependent decrease in the phosphorylation of an ErbB kinase signaling target p70S6-kinase T389 (by 60% in Z119 and 39% in Z181 cells at 3 µM). …”
  14. 634
  15. 635
  16. 636
  17. 637
  18. 638
  19. 639
  20. 640